Impact of endothelial activation on infective and inflammatory complications after cardiac surgery in type II diabetes mellitus

International Journal of Artificial Organs

Volumn 34, Issue 6, 2011, Pages 469-480

  Onorati, Francesco ^a   Rubino, Antonino S ^b   Cuda, Aldo ^b   Foti, Daniela ^b   Sica, Vincenzo ^c   Santini, Francesco ^a   Gulletta, Elio ^b   Renzulli, Attilio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiopulmonary bypass; Cytokine; Diabetes; Endothelial response; Infections; Systemic inflammatory response

Indexed keywords

CARDIOVASCULAR SURGERY; ENDOTHELIAL CELLS; HEMODYNAMICS;

CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; CYTOKINE RESPONSE; CYTOKINES; DIABETICS PATIENTS; ENDOTHELIAL RESPONSE; INFECTION; INFLAMMATORY RESPONSE; MONOCYTE CHEMOTACTIC PROTEIN-1; SYSTEMIC INFLAMMATORY RESPONSE;

CHEMICAL ACTIVATION;

INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INFECTION; INFLAMMATION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD;

EID: 79960065969     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/IJAO.2011.8329     Document Type: Article

References (25)

1. ACE/ADA Task Force on Inpatient Diabetes. American Collegeof Endocrinology and American Diabetes AssociationConsensus Statement on inpatient diabetes and glycemiccontrol. Diabetes Care 2006; 29 (8): 1955-62. Medline. doi:10.2337/dc06-9913
2. Cohen Y, Raz I, Merin G, Mozes B. Comparison of factorsassociated with 30-day mortality after coronary artery bypassgrafting in patients with versus without diabetes mellitus. Am J Cardiol 1998; 81: 7-11. Medline. doi:10.1016/S0002-9149(97)00797-2
3. Butler J, Rocker GM, Westaby S. Inflammatory response tocardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-9. Medline. doi:10.1016/0003-4975(93)91048-R
4. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuousintravenous insulin infusion reduces the incidence of deepsterna wound infection in diabetic patients. Ann ThoracSurg 1999; 67 (2): 352-60. Medline. doi:10.1016/S0003-4975(99)00014-4
5. Matata BM, Galinanes M. Cardiopulmonary bypass exacerbatesoxidative stress but does not increase pro-inflammatorycytokine release in patients with diabetes comparedwith patients without diabetes: regulatory effects of exogenousnitric oxide. J Thorac Cardiovasc Surg 2000; 120: 1-11. Medline. doi:10.1067/mtc.2000.106835
6. Verma S, Maitland A, Weisel RD, et al. Increased endothelin-1production in diabetic patients after cardioplegic arrest andreperfusion impairs coronary vascular reactivity: reversal bymeans of endothelin antagonism. J Thorac Cardiovasc Surg 2002; 123: 1114-9. Medline. doi:10.1067/mtc.2002.121972
7. Nawas SI, Doherty JC, Vigneswaran WT, et al. Cardiopulmonarybypass increases coronary IL-8 in diabetic patientswithout evidence of reperfusion injury. J Surg Res 1999; 84:46-50. Medline. doi:10.1006/jsre.1999.5602
8. Chello M, Mastroroberto P, Cirillo F, et al. Neutrophil-endothelialcell modulations in diabetic patients undergoing coronaryartery bypass grafting. Eur J Cardiothorac Surg 1998; 14:373-9. Medline. doi:10.1016/S1010-7940(98)00222-X
9. Onorati F, Santarpino G, Tangredi G, et al. Intra-aortic balloon pump induced pulsatile perfusion reduces endothelialactivation and inflammatory response following cardiopulmonarybypass. Eur J Cardiothorac Surg 2009; 35: 1012-9.Medline. doi:10.1016/j.ejcts.2008.12.037
10. Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized,controlled trial to evaluate blood glucose control by the modelpredictive algorithm versus routine glucose management protocolsin intensive care unit patients. Diabetes Care 2006; 29:271-6. Medline. doi:10.2337/diacare.29.02.06.dc05-1689
11. Asimakopoulos G, Smith PLC, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome aftercardiopulmonary bypass. Ann Thorac Surg 1999; 68: 1107-15. Medline. doi:10.1016/S0003-4975(99)00781-X
12. Khalpey ZI, Ganim RB, Rawn JD. Postoperative Care of CardiacSurgery Patients. In: Cohn LH. Cardiac Surgery in theAdult. New York: McGraw-Hill; 2008: 465-86.
13. Hornick P, Taylor KM. Pulsatile and non pulsatile perfusion:the continuing controversy. J Cardiothorac Vasc Anesth 1997;11: 310-5. Medline. doi:10.1016/S1053-0770(97)90100-2
14. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction:a clinical perspective. Endocr Rev 2001; 22: 36-52. Medline. doi:10.1210/er.22.1.36
15. Voisine P, Ruel M, Khan TA, et al. Differences in gene expressionprofiles of diabetic and non-diabetic patientsundergoing cardiopulmonary bypass and cardioplegic arrest. Circulation 2004; 110: II-280-II-286. doi:10.1161/01.CIR.0000138974.18839.02
16. Price CL, Al Hassi HO, English NR, Blakemore AI, Stagg AJ,Knight SC. Methylglyoxal modulates immune responses: relevanceto diabetes. J Cell Mol Med 2010; 14 (6B): 1806-15.
17. Franke A, Lante W, Fackeldey V, et al. Proinflammatory andantiinflammatory cytokines after cardiac operation: differentcellular sources at different times. Ann Thorac Surg 2002;74: 363-70. Medline. doi:10.1016/S0003-4975(02)03658-5
18. Lehle K, Preuner JG, Vogt A, et al. Endothelial cell dysfunctionafter coronary artery bypass grafting with extracorporealcirculation in patients with type 2 diabetes mellitus. Eur JCardiothorac Surg 2007; 32: 611-6. Medline. doi:10.1016/j.ejcts.2007.06.027
19. Itescu S, John R. Interactions between the recipient immunesystem and the left ventricular assist device surface: immunologicaland clinical implications. Ann Thorac Surg 2003;75: S58-65. Medline. doi:10.1016/S0003-4975(03)00480-6
20. Zedler S, Bone RC, Baue AE, von Donnersmarck GH, FaistE. T-cell reactivity and its predictive role in immunosuppressionafter burns. Crit Care Med 1999; 27: 66-72 Medline. doi:10.1097/00003246-199901000-00028
21. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelialcell injury in cardiovascular surgery: the systemic inflammatoryresponse. Ann Thorac Surg 1997; 63: 277-84. Medline. doi:10.1016/S0003-4975(96)01061-2
22. Menasche P, Edmunds LH. Extracorporeal Circulation: TheInflammatory Response. In: Cohn LH, Edmunds LH, eds.Cardiac Surgery in the Adult. New York: McGraw-Hill; 2003:349-60.
23. Castellheim A, Hoel TN, Videm V, et al. Biomarker profile inof-pump and on-pumpcoronary artery bypas grafting surgeryinlow-risk patients. Ann Thorac Surg 2008; 85: 1994-2002. Medline. doi:10.1016/j.athoracsur.2008.03.012
24. Fisher AB, Chien S, Barakat AI, Nerem RM. Endothelial cellularresponse to altered shear stress. Am J Physiol LungCell Mol Physiol 2001; 281: L529-33. Medline.
25. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces,and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9. Medline. doi:10.1111/j.1749-6632.2000.tb06318.x